↓ Skip to main content

Dove Medical Press

Lopinavir/ritonavir in the treatment of HIV-1 infection: a review

Overview of attention for article published in Therapeutics and Clinical Risk Management, October 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news
3 news outlets
twitter
2 X users
patent
1 patent
video
1 YouTube creator

Citations

dimensions_citation
215 Dimensions

Readers on

mendeley
293 Mendeley
Title
Lopinavir/ritonavir in the treatment of HIV-1 infection: a review
Published in
Therapeutics and Clinical Risk Management, October 2008
DOI 10.2147/tcrm.s3285
Pubmed ID
Authors

Ashish Chandwani, Jonathan Shuter

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 293 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
South Africa 1 <1%
Unknown 291 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 42 14%
Student > Master 41 14%
Student > Ph. D. Student 38 13%
Researcher 27 9%
Student > Postgraduate 14 5%
Other 45 15%
Unknown 86 29%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 48 16%
Medicine and Dentistry 41 14%
Biochemistry, Genetics and Molecular Biology 34 12%
Agricultural and Biological Sciences 21 7%
Chemistry 20 7%
Other 41 14%
Unknown 88 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 29. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 October 2023.
All research outputs
#1,363,279
of 25,837,817 outputs
Outputs from Therapeutics and Clinical Risk Management
#52
of 1,325 outputs
Outputs of similar age
#3,242
of 104,495 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#2
of 13 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,325 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.8. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 104,495 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.